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 48 
Abstract 49 
 50 
Objective: The multifunctional NS1 protein of influenza A virus has roles in antagonising 51 
cellular innate immune responses and promoting viral gene expression.  To better 52 
understand the interplay between these functions, we tested the effects of NS1 effector 53 
domain mutations known to affect homo-dimerisation or interactions with cellular PI3 54 
kinase or Trim25 on NS1 ability to promote nuclear export of viral mRNAs. 55 
 56 
Results: The NS1 dimerisation mutant W187R retained the functions of binding cellular 57 
NXF1 as well as stabilising NXF1 interaction with viral segment 7 mRNAs and promoting 58 
their nuclear export. Two PI3K-binding mutants, NS1 Y89F and Y89A still bound NXF1 but no 59 
longer promoted NXF1 interactions with segment 7 mRNA or its nuclear export. The Trim25-60 
binding mutant NS1 E96A/E97A bound NXF1 and supported NXF1 interactions with segment 61 
7 mRNA but no longer supported mRNA nuclear export. Analysis of WT and mutant NS1 62 
interaction partners identified hsp70 as specifically binding to NS1 E96A/E97A. Whilst these 63 
data suggest the possibility of functional links between NS1’s effects on intracellular 64 
signalling and its role in viral mRNA nuclear export, they also indicate potential pleiotropic 65 
effects of the NS1 mutations; in the case of E96A/E97A possibly via disrupted protein folding 66 
leading to chaperone recruitment. 67 
 68 
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Introduction  72 
 73 
Influenza A virus (IAV) infects both man and animals, including species important for food 74 
security [1]. A better understanding of its replication cycle is important to aid control 75 
measures. Like all viruses, IAV co-opts multiple cellular systems for replication and also has 76 
to counteract innate immune defence mechanisms. A key virally-encoded factor in both 77 
processes is the NS1 protein. As a nuclear-replicating virus, IAV utilises the NXF1 cellular 78 
mRNA export pathway to direct several of its mRNAs to the cytoplasm [2] and we and 79 
others have recently found that NS1 acts as an adaptor between segment 7 mRNAs 80 
(encoding the M1 or M2 proteins) and cellular mRNA processing/export pathways [3, 4]. 81 
NS1 is also the primary viral antagonist of innate immune responses, interfering with the 82 
function of multiple cellular polypeptides including PKR, 2’-OAS, CPSF30 and Trim25 [5]. NS1 83 
also activates the phosphoinositide 3-kinase (PI3K) complex, possibly to inhibit apoptosis 84 
[6]. Structurally, NS1 consists of an N-terminal RNA-binding domain and a C-terminal 85 
“effector” domain followed by a disordered tail, with no identified enzymatic activities. 86 
Instead, it functions by binding to multiple different proteins and RNAs (viral and cellular) 87 
and altering their activities [5]. Various NS1 point mutations have been identified that 88 
inhibit these interactions and comparative analyses of the behaviour of wild type (WT) and 89 
mutant IAV strains with these alterations have provided important information on the 90 
biological significance of each particular function. Here, we tested whether mutations 91 
identified as affecting NS1 interactions with the p85ß subunit of PI3K (Y89A and Y89F), 92 
Trim25 (E96A/E97A) and NS1 effector domain-mediated oligomerisation (W187R) [7-11] 93 
also affected NS1’s ability to promote nuclear export of segment 7 viral mRNAs.  94 
 95 
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 96 
Methods. 97 
All IAV plasmid constructs and viruses were based on the A/PR/8/34 (PR8) strain described 98 
previously [12]. NS1 mutations used in this study were introduced by standard PCR 99 
mutagenesis reactions; primer sequences are available on request. Methods for virus 100 
reverse genetics, infection, minireplicon assays, fluorescent in situ hybridization (FISH), 101 
immunofluorescence and confocal microscopy, GFP-trap pulldowns, western blots and 102 
reverse transcriptase-radioactive primer extension are described elsewhere [4]. LC-MS 103 
analysis was performed using a RSLCnano system (Thermo Fisher Scientific) coupled to a 104 
micrOTOF QII mass spectrometer (Bruker) on in-gel trypsin digested protein bands excised 105 
from Coomassie Blue-stained SDS-PAGE gels [13]. Raw spectral data were processed to peak 106 
lists and searched using Mascot 2.4 server (Matrix Science) against the Uniprot Human 107 
sequence database containing 93,786 entries. 108 
 109 
Results.  110 
Our previous work led to the hypothesis of NS1 acting as an adaptor protein to feed 111 
viral segment 7 mRNA(s) into the cellular NXF1 export pathway, by forming a ternary 112 
complex between NS1, NXF1 and the mRNA that requires both the NS1 effector domain and 113 
a functional RNA-binding domain [4]. To further test the role of the NS1 effector domain, a 114 
set of point mutations in this region of the protein were tested (Table 1), firstly in a subviral 115 
“minireplicon” system. 293T cells were transfected with plasmids to produce segment 7 116 
ribonucleoproteins (RNPs) as well as with either WT or mutant NS1s as EGFP-fusion 117 
proteins. Cells were fixed 24 h post transfection and segment 7 mRNA localisation detected 118 
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Table 1. Genetic and phenotypic summary of the NS1 polypeptides used in this study. 120 
NS1 protein mRNA 
export 
NXF1 
binding 
M1 mRNA 
binding 
Functional alteration Reference 
WT + + + n/a 
[12] 
N81
a,b
 - - - Effector domain deletion 
[14] 
R38A/K41A
 b
 - - - dsRNA-binding 
[15] 
F103S/M106I
 b
 + + + Gain of CPSF inhibition 
[16] 
Y89A - + - PI3K-binding 
[17] 
Y89F - + - PI3K-binding 
[8] 
E96A/97A - + + Trim25-binding 
[9] 
W187R + + + Homo-dimerisation 
[11] 
a
Stop codon added at position 82. 
b
See [4] for experimental data. 121 
 122 
by FISH (Figure 1A). NS1 expression was confirmed by detection of GFP signal as well as by 123 
western blot, although the E96A/E97A mutant accumulated to lower levels than the other 124 
NS1s (Figure 1B). WT NS1-GFP and most mutant proteins localised largely to the cytoplasm, 125 
but the W187R mutant was found both in nucleus and cytoplasm (Figure 1A). No mRNA 126 
staining was detected in the negative control lacking a complete RNP. As expected [4], 127 
when the minimal components for RNP reconstitution were present, segment 7 mRNA was 128 
detected primarily in cell nuclei, whilst on addition of NS1-GFP, it translocated to the 129 
cytoplasm. However, in the presence of PI3K-binding mutants NS1-Y89A or NS1-Y89F or the 130 
Trim25-binding mutant NS1-E96A/E97A, segment 7 mRNA was clearly still retained in the 131 
nucleus. In contrast, the dimerization mutant NS1-W187R caused segment 7 mRNA to 132 
localise to the cytoplasm. To quantify these effects, cells were visually scored according to 133 
the predominant cellular localisation of segment 7 mRNA (nuclear, cytoplasmic or both). In 134 
the absence of NS1, segment 7 was mainly nuclear in ~80% of cells scored, while the 135 
remaining cells presented mRNA staining both in the nucleus and the cytoplasm (Figure 1C). 136 
When WT NS1 or NS1-W187R were added, a statistically significant shift of segment 7 mRNA 137 
localisation was confirmed, with ~ 75% of cells showing mRNA in the cytoplasm. However, 138 
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addition of NS1-E96A/E97A, NS1-Y89A or NS1-Y89F did not produce this shift, with a clear 139 
majority of cells displaying nuclear segment 7 mRNA, similarly to samples with no NS1-GFP.  140 
To further test the mRNA export activity of the NS1 effector domain mutants, their 141 
phenotype was examined in the context of virus infection. 293T cells were mock infected or 142 
infected with either WT PR8 or the NS1 mutant viruses and at 6 h post infection (p.i.), fixed 143 
and processed for segment 7 FISH analysis as well as immunofluorescently stained for NS1 144 
(Figure 1D). All viruses generally gave cytoplasmic NS1 signal above the uninfected cell 145 
background, although staining of cells infected with NS1-Y89 and NS1-E96A/E97A mutants 146 
was noticeably fainter than the WT and W187R viruses. No viral mRNA signal was detected 147 
in the mock sample while segment 7 mRNA was cytoplasmic in WT and W187R virus-148 
infected cells. In cells infected with NS1-Y89A, NS1-Y89F and NS1-E96A/E97A, segment 7 149 
mRNA was predominantly nuclear. Thus, in both minireplicon and viral settings, the NS1 150 
dimerization mutant W187R supported normal segment 7 mRNA nuclear export, but the 151 
PI3K-binding and Trim25-binding mutants showed loss-of-function. 152 
NS1 both binds NXF1 and promotes the ability of NXF1 to bind segment 7 mRNA [4, 153 
18-20]. To test whether the effector domain mutants retained NXF1-binding activity, 293T 154 
cells were transfected with either GFP or GFP-NXF1 and 48 h later mock infected or infected 155 
with the panel of viruses. At 6 h p.i., cells were lysed and GFP-Trap precipitations were 156 
performed on the supernatants. Western blot analyses of total and bound fractions showed 157 
that GFP and GFP-NXF1 were both expressed and collected in comparable amounts (Figure 158 
2A). Blotting for NS1 confirmed successful infection, although the NS1-E96A/E97A 159 
polypeptide again accumulated to lower levels than the other NS1s. Nevertheless, all NS1 160 
polypeptides co-precipitated with GFP-NXF, indicating that the mutations did not abrogate 161 
the interaction. 162 
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To test whether the effector domain mutations affected the ability of NS1 to 163 
promote a stable interaction between NXF1 and segment 7 mRNA, 293T cells were 164 
transfected with GFP or GFP-NXF1 and infected with WT or mutant viruses as above. At 6 h 165 
p.i., cells were lysed and total RNA was extracted before or after the lysates had been 166 
subjected to GFP-Trap pulldown. Segment 7 RNA species were then detected by primer 167 
extension. Viral mRNAs and genomic vRNA were detected in the total fraction of every 168 
infected sample (Figure 2B, lanes 1-2 and 4-7). Analysis of the bound fraction from WT virus 169 
infected cells showed that both segment 7 mRNA species but not genomic vRNA co-170 
precipitated with GFP-NXF1 (lane 9) while no viral RNAs bound to GFP alone (lane 8), 171 
consistent with previous work [4, 18]. In contrast, viral mRNAs were not detected in GFP-172 
NXF1 pulldowns from cells infected with either NS1-Y89A or NS1-Y89F viruses (lanes 11 and 173 
12). The NS1-W187R and -E96A/E97A mutants also supported NXF1 interactions with the 174 
viral mRNAs (lane 13, 14). Since the E96A/E97A mutation blocked successful nuclear export 175 
of segment 7 mRNA, this finding indicated that, like the interaction between NS1 and NXF1, 176 
the interaction between NXF1 and segment 7 is necessary, but not sufficient for the 177 
successful nuclear export of segment 7 mRNA. 178 
The behaviour of the NS1 E96A/E97A mutant – unable to mediate nuclear export of 179 
segment 7 mRNA despite binding to NXF1 and promoting its interaction with the mRNA – 180 
suggested the involvement of another essential factor in the hypothesised ternary export 181 
complex. Accordingly, we examined cellular interaction partners of WT NS1 and the 182 
mutants, including a complete deletion of the effector domain (NS1-N81), an RNA-binding 183 
domain mutant (R38A/K41A) and a gain-of-function mutant that restores CPSF30-binding 184 
activity (F103S/M106I), of which only the latter supported mRNA nuclear export (Table 1; 185 
[4]). 293T cells were transfected with GFP or GFP-tagged NS1 mutant plasmids. Two days 186 
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later, cells were collected, lysed and subjected to GFP-Trap. Bound fractions were loaded 187 
onto SDS-PAGE gels and stained with Coomassie Blue. No obvious contamination from 188 
cellular GFP-binding proteins was seen from cells transfected with the GFP control plasmid 189 
(Figure 2C, lane 1). Major polypeptide species of the expected size were detected in all 190 
other samples, including the truncated form NS1-N81, confirming successful expression 191 
(lanes 2-9). Various other minor polypeptide species were also visible that were mostly 192 
common to all NS1-containing samples. However, one clear difference was observed; a 193 
distinct novel polypeptide in the E96A/E97A preparation (lane 8) that was absent from 194 
other samples. LC-MS analysis of the excised band unambiguously identified this 195 
polypeptide as heat shock protein 70 (hsp70) through multiple peptide matches (Table S1).  196 
To confirm the interaction between NS1-E96A/E97A and hsp70, repeat GFP-trap 197 
pulldowns were analysed by western blotting for hsp70 as well as for the GFP-tagged “bait” 198 
proteins. Transfection was confirmed by the detection of GFP and GFP-tagged NS1 mutant 199 
proteins, while equivalent amounts of the cellular proteins hsp70, Nup62 and UAP56 in the 200 
total fractions of all samples confirmed that comparable amounts of cell lysates had been 201 
generated (Figure 2D, lanes 1-9). However, in the bound fraction, hsp70 was detected only 202 
in the NS1-E96A/E97A sample (lane 17), confirming the specific interaction with hsp70 for 203 
NS1 E96A/E97A. 204 
 205 
Discussion 206 
The data reported here extend our previous investigation [4] into the role of NS1 in 207 
facilitating nuclear export of viral mRNA. Firstly, we show that higher order multimerization 208 
of NS1 via its effector domain is not needed for viral mRNA nuclear export. Secondly, the 209 
finding that point mutations in the NS1 effector domain, and not just its complete deletion 210 
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along with the C-terminal unstructured region [4], can block viral mRNA nuclear export, 211 
strengthens the argument for the functional involvement of this domain in the process. 212 
Thirdly, identification of an NS1 mutant (E96A/E97A) that still binds NXF1 and enhances its 213 
interaction with segment 7 mRNA without upregulating mRNA nuclear export suggests that 214 
at least one other factor is needed for export. Finally, the effect of mutations previously 215 
considered to specifically inhibit PI3K activation or inhibition of RIG-I signalling on M1 mRNA 216 
localisation could suggest the involvement of one or both of these pathways in viral mRNA 217 
nuclear export.   218 
Of broader significance than the mechanism of IAV mRNA nuclear export, our data 219 
add to the evidence suggesting pleiotropic effects from NS1 mutations commonly used as 220 
tools to interrogate viral interactions with the PI3K and RIG-I pathways (e.g. [10, 17, 21-221 
28]). Potential pleiotropic effects of the E96A/E97A mutation have been noted previously, 222 
including poor expression of the polypeptide as seen here [25] and an intriguing effect on 223 
PI3K activation [29]. Indeed a recent report detailing the crystal structure of NS1-Trim25 224 
complexes concluded that NS1 residues E96 and 97 do not directly contact Trim25 but 225 
instead support a network of contacts within the local region of the effector domain in 226 
which L95 and S99 actually make contact with Trim25 [30]. Our finding that the E96A/E97A 227 
mutation also induces binding of hsp70 further suggests effects on protein folding and that 228 
interpreting results obtained with this mutation may be complicated. 229 
 230 
Limitations 231 
Attempts to probe the role of PI3K activation in IAV mRNA export using small molecule 232 
inhibitors gave inconsistent results (data not shown) and could not be further pursued 233 
because of time and funding constraints. It would also have been interesting to test the 234 
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effects of hsp70 inhibitors [31] had time allowed. The effect of NS1 mutations L95A/S99A on 235 
mRNA export should also be tested. 236 
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Figures and Legends  260 
 261 
 262 
 263 
Figure 1. Effect of mutations in the NS1 effector domain on segment 7 mRNA localisation. 264 
A-C) 293T cells were transfected with plasmids to recreate segment 7 RNPs or, as a negative 265 
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control with a combination that excluded a plasmid expressing PB2 (2PNP), together with 266 
the indicated NS1-GFP polypeptides. (A) Cells were processed for FISH analysis at 24 h post 267 
transfection (p.t.) using Cy3-labelled RNA probes for detection of positive sense segment 7 268 
viral RNAs (red). GFP fluorescence was also detected (green). Images were captured using a 269 
Leica-TCS confocal microscope and Leica TCS analysis software. (B) Duplicate cell samples 270 
were lysed and examined by SDS-PAGE and western blotting for GFP and tubulin. (C) 271 
Individual cells were scored according to the predominant cellular localisation of segment 7 272 
mRNA considering three phenotypes: nuclear, cytoplasmic or mixed. Values are the mean ± 273 
range from two independent experiments. A 2-way ANOVA was used to test for statistically 274 
significant differences between the values for each category from those obtained for WT-275 
NS1 (NS, not significant; **** P < 0.0001).  (D) 293T cells were mock infected or infected 276 
with the indicated viruses at an M.O.I. of 5. At 6 h post infection (p.i.), cells were processed 277 
for FISH as above (red) and stained with anti-NS1 serum (green) and DAPI (for DNA; blue). 278 
Scale-bars indicate 10 µm. Lanes 1 and 2 in panel (B) and a portion of the corresponding 279 
numerical data in panel (C) are taken with permission from Figure 4C and 4B respectively of 280 
[4]. 281 
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 283 
 284 
Figure 2. Interactions between NS1, cellular proteins and segment 7 mRNAs. (A) 293T cells 285 
were transfected with plasmids encoding GFP or GFP-NXF1 and 48 h later either mock 286 
infected or infected with the indicated NS1 mutant viruses at an M.O.I. of 5. Cells were 287 
harvested at 6 h p.i. and cell lysates examined by western blotting for the indicated proteins 288 
before (Total) or after (Bound) being subjected to GFP-Trap pulldown assays. (B) 293T cells 289 
were transfected with GFP-NXF1 (GFP-NXF1 +) or with GFP alone (GFP-NXF1 -) and 48 h later 290 
either mock infected or infected with the indicated viruses at an M.O.I. of 10, in duplicate 291 
sets. At 6 h p.i., cells were harvested and total cellular RNA was extracted from one set 292 
while the second set was subjected to GFP-Trap pulldown assays prior to total RNA 293 
extraction. RNA was analysed by reverse transcription with radiolabelled primers specific for 294 
segment 7 RNAs followed by urea-PAGE and autoradiography. (C, D) 293T cells were 295 
transfected with either GFP alone or with GFP-tagged NS1 mutant protein expressing 296 
plasmids as indicated and 48 h later cells were harvested and subjected to GFP-Trap pull 297 
down assays. Eluted samples were loaded onto SDS-PAGE gels and (C) stained with 298 
Coomassie Blue dye or (D) western blotted for GFP or hsp70 before (Totals) or after (Bound) 299 
GFP-trap fractionation. Lanes 1-3 and 8-10 from panel (A) are reproduced with permission 300 
from Figure 7 of [4]. 301 
 302 
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